4 studies to know from HRS 2026
Boston Scientific, Abbott and Medtronic shared new cardiac device data at the annual Heart Rhythm Society meeting, where market share shifts in pulsed field ablation were on analysts’ minds.
Boston Scientific, Abbott and Medtronic shared new cardiac device data at the annual Heart Rhythm Society meeting, where market share shifts in pulsed field ablation were on analysts’ minds.
The FDA-cleared radiofrequency guidewire will slot into J&J’s fast-growing cardiovascular portfolio.
Butterfly, which makes handheld imaging machines, hopes to make the technology accessible to more patients with its pricing and AI features.
By April Miller - When health systems acquire electronic health record add-ons, end users typically have high expectations that these purchases will help them make better clinical decisions, improve patient care and speed up workflows. Yet to get the most out of these investments…
Anthropic’s Claude Mythos Preview has dominated security discussions since its April 7 announcement. Early reporting describes a powerful cybersecurity-focused AI system capable of identifying vulnerabilities at scale and raising serious questions about how quickly organizations …
Newly released episode of AI Amplified. Host Dr. Heather Bassett talks to Justin Schrager, MD, Co-Founder and Chief Medical Officer of Vital. They discussed his career transition from emergency medicine physician to tech entrepreneur, explaining how he co-founded Vital, a healthc…
Microsoft says it's rolling out a revamped Windows Insider Program experience as part of the broader plans to address performance and reliability concerns affecting Windows 11. [...]
We have rounded up some reports and surveys from around the industry that we thought were of interest from The Phia Group LLC, AHIP, Blue Cross Blue Shield Association, Physicians for a National Health Program, Carta Healthcare, Imagine Pediatrics, UnitedHealthcare, Eliciting Ins…
Microsoft is rolling out Windows Update improvements that give users more control over how updates are installed while reducing disruption from frequent or poorly timed restarts. [...]
Hundreds of subdomains from dozens of universities have been hijacked by scammers.
Microsoft will roll out passkey support for phishing-resistant passwordless authentication to Microsoft Entra‑protected resources from Windows devices starting late April. [...]
The stronger outlook follows mixed results from other major medical device makers in the latest quarter, after both Abbott and Boston Scientific cut their full-year guidance.
By Stephen Dean - Every week, I talk to health system leaders who have spent the last three years investing heavily in patient access technology. Scheduling tools. AI chatbots. Digital front doors. Nurse triage platforms. Intake apps. And nearly every one of them says some versio…
Forgotten integrations, shadow IT, SaaS, and now shadow AI and agents are everywhere, and attackers don't need sophisticated AI models to take advantage.
Johnson & Johnson sees surgeons’ familiarity with Ethicon devices as a differentiator as it enters a robot market dominated by Intuitive Surgical.
The AI Agent Authority Gap - From Ungoverned to Delegation As discussed in our previous article, AI agents are exposing a structural gap in enterprise security, but the problem is often framed too narrowly. The issue is not simply that agents are new actors. It is that agents are…
Microsoft says IT administrators can now uninstall the AI-powered Copilot digital assistant from enterprise devices using a new policy setting, which has become broadly available after the April 2026 Patch Tuesday. [...]
The company plans to introduce AI agents for personas such as sales reps, leadership and marketing teams.
Newly Release FINN Voices episode with Beth Friedman and Andy Ottum, AI Advances Executive Decisions at HIMSS'26. Discussion on a challenge that has quietly plagued healthcare for years, not a lack of data, but a failure to analyze it fast enough for strategic decision making. Th…
The pathway is designed to reduce the delay between FDA authorization and Medicare coverage for certain Class II and Class III breakthrough medical devices.